AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS (ASIPP) -- (Extensions of Remarks - September 08, 2005)
HON. FRANK PALLONE, JR.
OF NEW JERSEY
IN THE HOUSE OF REPRESENTATIVES
THURSDAY, SEPTEMBER 8, 2005
Mr. PALLONE. Mr. Speaker, earlier this summer the National All Schedules Prescription Electronic Reporting (NASPER) Act of 2005 was approved by both houses of Congress and signed into law by President Bush. I rise today to recognize the important contributions of Dr. Laxmaiah Manchikanti and the American Society of Interventional Pain Physicians (ASIPP) in accomplishing this important achievement.
Dr. Manchikanti is a physician of Indian origin who has practiced medicine in Paducah, Kentucky for the last 25 years. He is a well-known and well-respected physician with interests in many aspects of medicine, both in patient care, as well as academics.
Dr. Manchikanti is a recognized leader in the circles of interventional pain management. Apart from his interest in the clinical practice of anesthesiology and interventional pain management, he is also proficient in administrative medicine, patient advocacy, the economics of healthcare, medical ethics and various other aspects of the profession. He is an avid clinical researcher with numerous publications in peer-reviewed journals with original contributions.
Dr. Manchikanti currently serves as Chief Executive Officer of the American Society of Interventional Pain Physicians. With over 3,400 members, ASIPP is the largest organization in the country that represents physicians involved in trying to alleviate the intractable pain experienced by millions of Americans. Because of their professional involvement with pain medicine many ASIPP members have a vested interest in solving the problem of prescription drug abuse and diversion.
Mr. Speaker, one of the fastest growing areas of drug abuse in our nation today is the diversion of prescription drugs. According to the National Institute of Health--National Institute on Drug Abuse, approximately 9 million Americans are misusers of prescription drugs. Furthermore, in 2001 the National Household Survey on Drug Abuse, found statistically significant increases between 2000 and 2001 in the use of multiple drugs including non-medical use of pain relievers and tranquilizers.
Prescription drug abuse is an issue that transcends societal boundaries, and affects all areas of our nation and all income levels. In an effort to prevent prescription drug abuse the NASPER Act establishes a federal system for electronic prescription databanks, which a doctor could access to determine what, if any, medication their patient should be given.
From the very beginning, Dr. Manchikanti and his colleagues at ASIPP have played a crucial role in the development of the NASPER Act. Thanks to their active involvement and insightful guidance, we were able to craft a thoughtful policy that will give physicians, pharmacists, and law enforcement agents the tools necessary to curb prescription drug abuse.
Mr. Speaker, next week ASIPP will hold its 7th annual legislative session in Washington. I would like to welcome ASIPP to our nation's capital, and offer my gratitude for all of their efforts over the past several years. Thanks to the hard work of Dr. Manchikanti and all of his colleagues the NASPER Act has finally become law and we can begin to address this very serious public health concern.
I must emphasize that this is only the beginning. There is still a lot of important work left to be done in terms of implementing and enforcing this new law. I am looking forward carrying my partnership with Dr. Manchikanti and ASIPP forward, as we continue to work together to help eliminate prescription drug abuse.